Boehringer Ingelheim, Pfizer to jointly market once-a-day SPIRIVA for Chronic Obstructive Pulmonary Disease
Ingelheim, Germany, and New York (ots-PRNewswire) - Boehringer Ingelheim and Pfizer Inc announced today that they have entered into a long-term worldwide agreement to jointly market SPIRIVA(r) (tiotropium), a novel once-a-day inhaled treatment for Chronic Obstructive Pulmonary Disease (COPD), which includes ...